Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Neoplasms × pembrolizumab × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 79 Melanoma 60 Squamous Cell Carcinoma of Head and Neck 41 Breast Neoplasms 35 Parkinson Disease 4, Autosomal Dominant Lewy Body 32 Lung Neoplasms 29 Carcinoma, Renal Cell 29 Neoplasm Metastasis 28 Colorectal Neoplasms 28 Neoplasms 27 Ovarian Neoplasms 24 Triple Negative Breast Neoplasms 23 Stomach Neoplasms 19 Head and Neck Neoplasms 16 Urinary Bladder Neoplasms 15 Carcinoma, Transitional Cell 14 Pancreatic Neoplasms 13 Prostatic Neoplasms 12 Uterine Cervical Neoplasms 11 Endometrial Neoplasms 11 Esophageal Neoplasms 10 Sarcoma 9 Fallopian Tube Neoplasms 9 Carcinoma, Squamous Cell 9 Carcinoma, Hepatocellular 9 Carcinoma 9 Skin Neoplasms 8 Colonic Neoplasms 8 Small Cell Lung Carcinoma 7 Cholangiocarcinoma 7

Interventions

pembrolizumab 1 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420884 2025-06-13

iintune-1

Takeda

Phase 1/2 Active not recruiting

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡